APYX NASDAQ
Credit Risk of going bust: higher than 78% of companies Debt: 27.7% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.11 (down 96%), Apyx Medical Corporation would be worth roughly what it owes.
Total debt $39.6M against a stock market value of $103.6M.
Distance to default 2.78 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $17.7M (short-term plus half of long-term), stock volatility 73.6%; Altman Z'' -0.38. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Clearwater, FL 33760-4004
US
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The companyâs helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Waldman Lawrence | M-Exempt | 12,000 | $1.88 | 2026-06-30 |
| Waldman Lawrence | F-InKind | 5,024 | $4.49 | 2026-06-30 |
| Waldman Lawrence | M-Exempt | 12,000 | $1.88 | 2026-06-30 |
| Roman Shawn David | M-Exempt | 15,000 | $3.23 | 2026-06-15 |
| Roman Shawn David | F-InKind | 10,533 | $4.60 | 2026-06-15 |